tumsasedgars Shares of DigitalOcean ( DOCN ) fell about 2% premarket on Tuesday despite fourth quarter results beating estimates. The company's revenue outlook was above analysts' estimates, but EPS guidance came in below expectations. Q4 Metrics Non-GAAP EPS for the fourth quarter ended Dec. 31 fell about 10% year-over-year to $0.44, beating analysts estimates of $0.38. Revenue grew 18% year-over...
tumsasedgars Shares of DigitalOcean ( DOCN ) fell about 2% premarket on Tuesday despite fourth quarter results beating estimates. The company's revenue outlook was above analysts' estimates, but EPS guidance came in below expectations. Q4 Metrics Non-GAAP EPS for the fourth quarter ended Dec. 31 fell about 10% year-over-year to $0.44, beating analysts estimates of $0.38. Revenue grew 18% year-over-year to $242.4M, exceeding estimates of $237.73M. "AI is reshaping entire industries, and we are built for this shift. DigitalOcean’s Agentic Inference Cloud is gaining further traction with large Cloud and AI Native customers that are driving the shift, which is evident in our strong Q4 performance and our increased outlook for 2026 and 2027," said DigitalOcean's CEO Paddy Srinivasan. The company noted that its fourth quarter Remaining Performance Obligation, or RPO, was $134M, of which $73M is expected to be recognized over the next 12 months. RPO was $22M in the fourth quarter of 2024. Annual Run-Rate Revenue, or ARR, ended the quarter at $970M, an increase of 18% year-over-year, according to the company. Outlook For the first quarter, DigitalOcean — which operates a cloud computing platform — expects total revenue between $249M and $250M (midpoint at $249.5M) versus the consensus revenue estimate of $248.31M. The company expects non-GAAP net income per share in the range of $0.22 to $0.27 (midpoint at $0.245) compared to a consensus EPS estimate of $0.45. For the full year 2026, the company expects total revenue between $1.075B and $1.105B (midpoint at $1.09B) compared to a consensus revenue estimate of $1.07B. DigitalOcean expects non-GAAP net income per share in the range of $0.75 to $1.00 (midpoint at $0.875) compared to a consensus EPS estimate of $1.96. The company said it has raised its 2026 and 2027 revenue outlook after a strong fourth quarter of 2025 on the back of top customer growth and growing AI traction. "With this growing momentum, we are raising our gro...
First Watch Restaurant Group ( FWRG ) announced that chief financial officer Mel Hope has plans to retire later this year. The company has commenced a process to identify his successor, considering both internal and external candidates. It is expected that Hope will remain as chief financial officer until his successor is in place to ensure a seamless transition and serve as an advisor to the comp...
First Watch Restaurant Group ( FWRG ) announced that chief financial officer Mel Hope has plans to retire later this year. The company has commenced a process to identify his successor, considering both internal and external candidates. It is expected that Hope will remain as chief financial officer until his successor is in place to ensure a seamless transition and serve as an advisor to the company for a period thereafter. More on First Watch Restaurant First Watch Restaurant: A Progress Check 5 Years Post-IPO First Watch Is A Good Deal Right Now First Watch Restaurant beats Q4 street views First Watch gains after saying at ICR that its restaurant pipeline is strong Seeking Alpha’s Quant Rating on First Watch Restaurant
guvendemir/E+ via Getty Images Leonardo DRS Inc. ( DRS ) reported fourth-quarter results that topped Wall Street expectations, sending shares up 3.6% in premarket trading Tuesday. For the fourth quarter, the defense contractor posted revenue of $1.06 billion, ahead of the consensus estimate of $995 million and up 8% from $981 million a year earlier. Adjusted earnings per share came in at $0.42, be...
guvendemir/E+ via Getty Images Leonardo DRS Inc. ( DRS ) reported fourth-quarter results that topped Wall Street expectations, sending shares up 3.6% in premarket trading Tuesday. For the fourth quarter, the defense contractor posted revenue of $1.06 billion, ahead of the consensus estimate of $995 million and up 8% from $981 million a year earlier. Adjusted earnings per share came in at $0.42, beating estimates of $0.37 and rising from $0.38 in the prior-year period. Net income rose to $102 million, or $0.38 a share, from $89 million, or $0.33 a share. For the full year, Leonardo DRS ( DRS ) generated revenue of $3.65 billion, up 13% from $3.23 billion in 2024. Net earnings increased 31% to $278 million, or $1.03 a share, compared with $213 million, or $0.80 a share, a year earlier. Adjusted diluted EPS for the year was $1.15, up from $0.93. “Our 2025 results exemplify another year of exceptional customer demand and double-digit revenue growth,” John Baylouny, president and chief executive, said in a statement. “We are investing, innovating and delivering mission-critical capabilities at speed for our customers.” Earnings rise on volume and licensing deal Fourth-quarter earnings before interest, taxes, depreciation and amortization totaled $158 million, up 7% from $148 million a year earlier. The company said higher volume and the benefit of a quantum laser intellectual property license agreement supported growth, though margins were pressured by program mix and higher material input costs. For the full year, ebitda increased 13% to $453 million from $400 million in 2024. Full-year ebitda margin was 12.4%, flat with the prior year. Both the fourth quarter and full year were affected by two non-routine items. The company recorded a $73 million net present value benefit tied to a 10-year quantum laser IP license agreement. That gain was partially offset by a $67 million revenue headwind related to the conclusion of a legacy foreign ground surveillance program. Backlo...
Bowhead Specialty Holdings press release ( BOW ): Q4 NON-GAAP EPS of $0.47. Revenue of $151.6M. More on Bowhead Specialty Holdings Seeking Alpha’s Quant Rating on Bowhead Specialty Holdings Historical earnings data for Bowhead Specialty Holdings Financial information for Bowhead Specialty Holdings
Bowhead Specialty Holdings press release ( BOW ): Q4 NON-GAAP EPS of $0.47. Revenue of $151.6M. More on Bowhead Specialty Holdings Seeking Alpha’s Quant Rating on Bowhead Specialty Holdings Historical earnings data for Bowhead Specialty Holdings Financial information for Bowhead Specialty Holdings
FILE: Leon Black, chairman and chief executive officer of Apollo Global Management LLC, at the Milken Institute Global Conference in Beverly Hills, California, U.S., on Tuesday, May 1, 2018. Patrick T. Fallon | Bloomberg | Getty Images A version of this article first appeared in CNBC's Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up t...
FILE: Leon Black, chairman and chief executive officer of Apollo Global Management LLC, at the Milken Institute Global Conference in Beverly Hills, California, U.S., on Tuesday, May 1, 2018. Patrick T. Fallon | Bloomberg | Getty Images A version of this article first appeared in CNBC's Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. A $484 million art loan secured by billionaire Leon Black and disclosed in the latest Epstein files highlights one of the fastest-growing and most lucrative corners of the art world. According to a March 2015 document released as part of the Epstein files, Black secured the loan from Bank of America backed by works of art. While not unusual for top private banking clients, the loan made headlines for its size and the exotic collateral, which included blue-chip works by Picasso, Giacometti, Titian, Matisse and others. Art lending, however, has become an increasingly valuable tool for both wealthy collectors and the wealth management firms vying to manage their fortunes. The global market for art loans is estimated at between $38 billion and $45 billion today, according to a report from Deloitte and ArtTactic. The market is expected to top $50 billion by 2028, growing at about 12% a year. Adam Chinn, managing partner of International Art Finance and longtime art-finance expert, said art loans are a way for collectors to pull cash from paintings that they can also continue to enjoy on their walls. Get Inside Wealth directly to your inbox The Inside Wealth newsletter by Robert Frank is your weekly guide to high-net-worth investors and the industries that serve them. Subscribe here to get access today . "It's the best of both worlds," Chinn said. "You can monetize an otherwise non-income producing asset. And it's still great to look at." Far from signaling a lack of funds, art loans are typically used by the wealthy to provide r...
adventtr/iStock via Getty Images Overview My first look at GeneDx ( WGS ) was in December 2024. This is a company that deals in exome sequencing–with a focus on rare disease diagnosis. Back then, GeneDx was experiencing robust revenue growth–52% YoY–and operating leverage. However, I was a bit hesitant because–per my discounted cash flow analysis–GeneDx’s valuation implied expectations for 35% CAG...
adventtr/iStock via Getty Images Overview My first look at GeneDx ( WGS ) was in December 2024. This is a company that deals in exome sequencing–with a focus on rare disease diagnosis. Back then, GeneDx was experiencing robust revenue growth–52% YoY–and operating leverage. However, I was a bit hesitant because–per my discounted cash flow analysis–GeneDx’s valuation implied expectations for 35% CAGR over the next several years, which seemed optimistic. I ended at a “Hold/underperform” on WGS. Its stock has since changed 8.17% versus S&P 500 ( SPY ) gains of 13.15%, significantly underperforming relative to peers like NTRA , TXG , and SOPH . Seeking Alpha Below, I take a look at GeneDx’s Q4/FY25 results , its valuation, and what investors should keep tabs on moving forward. Earnings Q4 and FY25 revenue came in at $121 million (up 27% YoY) and $427.5 million (up 41% YoY), respectively. Its core business–exome and genome–grew 32% YoY to $104 million. So, as expected, GeneDx’s growth is beginning to decelerate–and notably fell under the 35% CAGR my model highlighted in December 2024 needed to support its valuation. The company expects FY26 revenue to fall between $540 million and $555 million, which implies ~26% to 30% YoY growth. Zooming out, things are headed in the right direction: Data derived from Seeking Alpha; limited data available on quarterly "Total Employees" count (Author's Compilation) What sticks out the most to me is the clear improvement in gross and free cash flow margins. And, importantly, the company is beginning to feel more comfortable reinvesting into its business (as evidenced by the R&D Intensity/Capital Intensity trends). Of course, the genomic industry is defined by rapid technological advancements that require capital to stay ahead. I can’t help but notice that WGS has been slashed in half since it reached ~$160/share in late November. The slide accelerated after the company prelimed its Q4/FY25 results in January. The fall appears to be due to...
Claim of ‘abetting terrorist activities’ comes as Kremlin attempts to steer users on to state-controlled app Russia has launched a criminal investigation into the Telegram founder, Pavel Durov, on suspicion of “abetting terrorist activities”, further escalating the Kremlin’s standoff with the widely used messaging app. The state newspaper Rossiyskaya Gazeta reported on Tuesday that a case had been...
Claim of ‘abetting terrorist activities’ comes as Kremlin attempts to steer users on to state-controlled app Russia has launched a criminal investigation into the Telegram founder, Pavel Durov, on suspicion of “abetting terrorist activities”, further escalating the Kremlin’s standoff with the widely used messaging app. The state newspaper Rossiyskaya Gazeta reported on Tuesday that a case had been opened “based on materials from Russia’s federal security service”, which accused the app of being compromised by western and Ukrainian intelligence. Continue reading...
NRG Energy press release ( NRG ): Q4 Non-GAAP EPS of $1.04. Revenue of $7.76B (+13.1% Y/Y). Exceeded 2025 raised financial guidance ranges; returned $1.6 billion of capital to shareholders Adjusted Earnings per Share (Adjusted EPS) growth rate target of 14%+ extended through 2030. Reaffirming 2026 Guidance On February 2, 2026, NRG announced updated guidance following the close of its acquisition o...
NRG Energy press release ( NRG ): Q4 Non-GAAP EPS of $1.04. Revenue of $7.76B (+13.1% Y/Y). Exceeded 2025 raised financial guidance ranges; returned $1.6 billion of capital to shareholders Adjusted Earnings per Share (Adjusted EPS) growth rate target of 14%+ extended through 2030. Reaffirming 2026 Guidance On February 2, 2026, NRG announced updated guidance following the close of its acquisition of a portfolio of assets and CPower from LS Power on January 30, 2026. The updated guidance reflects approximately 11 months of ownership of these assets in 2026. NRG is reaffirming its guidance for 2026 as set forth below. Table 2: Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, and FCFbG Guidance for 2026 a,b 2026 2026 (In millions, except per share amounts) Guidance Guidance Midpoint Adjusted Net Income $1,685 - $2,115 $1,900 Adjusted EPS $7.90 - $9.90 $8.90 vs. consensus of $9.13 Adjusted EBITDA $5,325 - $5,825 $5,575 FCFbG $2,800 - $3,300 $3,050 Click to enlarge
27-year-old Morocco international denies allegation Defender says trial ‘will allow the truth to come out’ Achraf Hakimi is to face trial for rape, the Paris Saint-Germain and Morocco defender confirmed via a social media post on Tuesday, going on to deny the allegation. “Today, a rape accusation is enough to justify a trial, even though I deny it and everything proves it’s false,” wrote Hakimi. “...
27-year-old Morocco international denies allegation Defender says trial ‘will allow the truth to come out’ Achraf Hakimi is to face trial for rape, the Paris Saint-Germain and Morocco defender confirmed via a social media post on Tuesday, going on to deny the allegation. “Today, a rape accusation is enough to justify a trial, even though I deny it and everything proves it’s false,” wrote Hakimi. “This is as unjust to the innocent as it is to the genuine victims. I calmly await this trial, which will allow the truth to come out publicly.“ Continue reading...
A short-lived rebound in stocks petered out as fears about the disruptive impact of artificial intelligence continued to unsettle markets.That's after tech, delivery and payment shares slid following a Citrini Research report outlining potential AI risks across industries. The weakness was compounded by lingering uncertainty over President Donald Trump's tariffs. Erik Wytenus is Head of EMEA Inves...
A short-lived rebound in stocks petered out as fears about the disruptive impact of artificial intelligence continued to unsettle markets.That's after tech, delivery and payment shares slid following a Citrini Research report outlining potential AI risks across industries. The weakness was compounded by lingering uncertainty over President Donald Trump's tariffs. Erik Wytenus is Head of EMEA Investment Strategy at JPMorgan Private Bank joins Stephen Carroll and Caroline Hepker to discuss. (Source: Bloomberg)
Justice secretary says only his measures will stop backlog in England and Wales from increasing exponentially The backlog in criminal courts in England and Wales will continue to rise for nearly a decade before it falls despite radical reforms including curtailing jury trials, according to figures from the Ministry of Justice. The justice secretary, David Lammy, said the government was determined ...
Justice secretary says only his measures will stop backlog in England and Wales from increasing exponentially The backlog in criminal courts in England and Wales will continue to rise for nearly a decade before it falls despite radical reforms including curtailing jury trials, according to figures from the Ministry of Justice. The justice secretary, David Lammy, said the government was determined to press ahead with the jury trial reforms despite a potential rebellion from Labour MPs, warning that no other measures would stop the backlog from rising exponentially. Continue reading...